AJPH
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

American Journal of Public Health, Vol. 85, Issue 11 1538-1542, Copyright © 1995 by American Public Health Association

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chitwood, D D
Right arrow Articles by McCoy, C B
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chitwood, D D
Right arrow Articles by McCoy, C B
Risk factors for HIV-1 seroconversion among injection drug users: a case-control study.

D D Chitwood, D K Griffin, M Comerford, J B Page, E J Trapido, S Lai and C B McCoy

Comprehensive Drug Research Center, University of Miami School of Medicine, FL 33136, USA.

OBJECTIVES. A nested case-control study was conducted in Miami, Fla, to determine risk factors associated with human immunodeficiency virus type 1 (HIV-1) seroconversion among injection drug users. METHODS. The study identified 21 incident cases of HIV-1 infection and 76 unmatched controls from two longitudinal cohorts of injection drug users. One cohort consisted of individuals who originally had been recruited from treatment centers; a second cohort was recruited from the "street." Logistic regression analyses that adjusted for age, gender, and race were performed. RESULTS. The final model determined that the primary independent risk factor that best explained the risk for seroconversion was sharing injection equipment in the year prior to conversion; a marginal risk factor was presence of sexually transmitted disease during this same period. CONCLUSIONS. Both an injection component and a sexual component play a role in seroconversion among injection drug users, although the injection component is much stronger.




This article has been cited by other articles:


Home page
 PediatricsHome page
E. G. Romero, L. A. Teplin, G. M. McClelland, K. M. Abram, L. J. Welty, and J. J. Washburn
A Longitudinal Study of the Prevalence, Development, and Persistence of HIV/Sexually Transmitted Infection Risk Behaviors in Delinquent Youth: Implications for Health Care in the Community
Pediatrics, May 1, 2007; 119(5): e1126 - e1141.
[Abstract] [Full Text] [PDF]

Home page
 Behav ModifHome page
K. Silverman, C. J. Wong, M. J. Grabinski, J. Hampton, C. E. Sylvest, E. M. Dillon, and R. D. Wentland
A Web-Based Therapeutic Workplace for the Treatment of Drug Addiction and Chronic Unemployment
Behav Modif, March 1, 2005; 29(2): 417 - 463.
[Abstract] [PDF]

Home page
 Qual Health ResHome page
A. M. Fenaughty and L. Namyniuk
"Here's What I'd Do ...": Condom Promotion Strategies Proposed by High-Risk Women in Anchorage, Alaska
Qual Health Res, January 1, 2004; 14(1): 23 - 38.
[Abstract] [PDF]

Home page
 Am J EpidemiolHome page
K. E. Nelson, N. Galai, M. Safaeian, S. A. Strathdee, D. D. Celentano, and D. Vlahov
Temporal Trends in the Incidence of Human Immunodeficiency Virus Infection and Risk Behavior among Injection Drug Users in Baltimore, Maryland, 1988-1998
Am. J. Epidemiol., October 1, 2002; 156(7): 641 - 653.
[Abstract] [Full Text] [PDF]

Home page
 The Prison JournalHome page
C. HEMMENS and J. W. MARQUART
Fear and Loathing in the Joint: The Impact of Race and Age on Inmate Support for Prison AIDS Policies
The Prison Journal, June 1, 1998; 78(2): 133 - 151.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American Public Health Association